Regn share price pre market
WebMar 31, 2024 · With Regeneron Pharmaceuticals stock trading at $821.67 per share, the total value of Regeneron Pharmaceuticals stock (market capitalization) is $89.83B. Regeneron Pharmaceuticals stock was originally listed at a price of $8.56 in Dec 31, 1997. WebApr 6, 2024 · View real-time REGN stock price and news, ... Market Value: $90.59B: Shares Outstanding: 107.51M: EPS ... comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 ...
Regn share price pre market
Did you know?
WebRegeneron (ticker: REGN) reported non-GAAP diluted earnings of $23.72 per share for the fourth quarter of 2024, beating the FactSet analyst consensus estimate of $20.40. WebRegeneron Pharmaceuticals (REGN) Profile. Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan. Number of employees 9,123 (2024) Total assets US$17.163 billion (2024) Market cap 67.26 B USD.
WebNov 8, 2024 · Regeneron Pharmaceuticals (REGN) – Shares of the pharmaceutical company rose 2% after Regeneron said that a single dose of its antibody cocktail could provide long-term protection against Covid-19. WebApr 12, 2024 · View real-time stock prices and stock quotes for a full financial overview. REGN ... Market Cap $89.59B; Shares Outstanding 107.51M; Public Float 104.63M;
Web1 day ago · REGN’s market cap is 90.78 Bil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s ... REGN’s price/book is 4.02. WebMarket Share; Company's Competition Performance; Company's Competitors Results; ... AUBNs' fourth quarter of 2024 financial report income per share elevated on the another level by 143.15 % to $1.28 per share in proportion to a year before on growing Sales of 45.96 % to $ 10.37 millions. ... REGN's Valuation : Price to Earnings PE Ratio (TTM)
WebMSN. REGN Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. REGENERON PHARMACEUTICALS, INC. 826.19.
WebRegeneron Pharma earnings beat by $2.39, revenue fell short of estimates. Investing.com - Regeneron Pharma (NASDAQ: REGN) reported fourth quarter EPS of $12.56, $2.39 better than the analyst estimate of $10.17. Revenue for … tesla lease uk businessWeb1 day ago · With an estimated net price of approximately $30,000 per patient per year and 500,000 patients, the addressable market for Dupixent in COPD alone is $15 billion and 10% to 20% market penetration ... rodi portugalWebBRIEF-Regent Enterprises swings to June-qtr profit. Aug 12 (Reuters) - Regent Enterprises Ltd REGN.BO : * June-quarter net profit 2.6 million rupees versus loss of 531,000 rupees last year * June-quarter net sales 1.69 billion rupees... More Regent Enterprises Ltd News & Analysis. Disclaimer: Fusion Media would like to remind you that the data ... rodi o zanteWeb102 rows · Discover historical prices for REGN stock on Yahoo Finance. View daily, weekly or monthly format back to when Regeneron Pharmaceuticals, Inc. stock was issued. tesla ladekabel abziehenWebApr 13, 2024 · Market Price = The current market price of the bond; Time to Maturity = The number of years remaining until the bond matures; Practical Example: Calculating Yield to Maturity for a Bond. Consider a bond with a face value of ₹1,000, an annual coupon rate of 6%, a market price of ₹900, and a time to maturity of 10 years. tesla lg 5l akkuWebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regeneron Pharmaceuticals, Inc.’s P/E ratio is 21.45. tesla lfp akku 100WebDec 31, 2009 · Tickers, Articles and Keywords: Tickers. Articles tesla line